Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 USD | -2.61% |
|
-6.56% | -30.30% |
06-03 | Vgxi Inc. Announces Strategic Partnership with Sutro Biopharma Inc. to Support Growing Clinical Pipeline | CI |
05-13 | Sutro Biopharma Q1 Loss Widens, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.30% | 251M | |
+16.45% | 123B | |
+21.96% | 115B | |
+23.73% | 25.85B | |
-20.05% | 20.9B | |
-16.28% | 16.77B | |
-16.52% | 16.52B | |
-44.35% | 15.56B | |
+63.91% | 15.49B | |
+2.52% | 13.45B |
- Stock Market
- Equities
- STRO Stock
- News Sutro Biopharma, Inc.
- Piper Sandler Adjusts Price Target on Sutro Biopharma to $12 From $18, Maintains Overweight Rating